| Title : Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease - Cacabelos_2020_Expert.Opin.Drug.Metab.Toxicol_16_673 |
| Author(s) : Cacabelos R |
| Ref : Expert Opin Drug Metab Toxicol , 16 :673 , 2020 |
| Abstract : Cacabelos_2020_Expert.Opin.Drug.Metab.Toxicol_16_673 |
| ESTHER : Cacabelos_2020_Expert.Opin.Drug.Metab.Toxicol_16_673 |
| PubMedSearch : Cacabelos_2020_Expert.Opin.Drug.Metab.Toxicol_16_673 |
| PubMedID: 32520597 |
Cacabelos R (2020)
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease
Expert Opin Drug Metab Toxicol
16 :673
Cacabelos R (2020)
Expert Opin Drug Metab Toxicol
16 :673